QualityStocksNewsBreaks – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) Featured in BioMedWire Editorial on AI-Powered Intoxication Detection
This article has been disseminated on behalf of MindBio Therapeutics Corp. and may include paid advertising. MindBio Therapeutics (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) announced its placement in a BioMedWire editorial exploring emerging technologies aimed at improving intoxication detection across law enforcement, workplace safety and healthcare settings. The editorial highlights MindBio’s development of an artificial intelligence-driven voice analysis platform designed to detect real-time impairment from short speech samples, positioning the company within a growing movement toward noninvasive diagnostic technologies with potential applications across public safety, regulatory enforcement and health monitoring. To view the full press release, visit https://ibn.fm/Ib2KB About MindBio…